As shown in Figure 1E, treatment of Colo205 tumour-bearing mice with 60 mg kg−1 dulanermin resulted in a robust increase in tumour caspase 3 staining that was readily detectable at 8 and 24 h, and began to decrease by 72 h. This evidence concerns the gene CASP3 and neoplasm.